MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/immadv/ltaf027

Медицинская библиотека · Immunotherapy advances · 2025

Head-to-head comparison of nuclear imaging approaches to quantify tumor CD8+ T-cell infiltration.

Sandker Gerwin G W, Raavé René, Antunes Inês F, Boswinkel Milou, Cornelissen Lenneke A M, Franssen Gerben M, Molkenboer-Kuenen Janneke, Wierstra Peter J, Hagemans Iris M, de Vries Erik F J, Bussink Johan, Adema Gosse J, Verdoes Martijn, Aarntzen Erik H J G, Heskamp Sandra

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Many immunotherapies focus on (re)invigorating CD8+ T cell anti-cancer responses. Different nuclear imaging techniques have been developed to measure CD8+ T cell distributions. Comprehensive comparisons of in vivo and ex vivo T cell labeling methods with respect to tumor and normal tissue targeting and correlation with CD8⁺ T cell presence are lacking, but essential for accurate clinical interpretation. We performed a head-to-head comparison of three CD8+ T cell imaging approaches: 89Zr-labeled Fc-silent anti-CD8 antibody ([89Zr]Zr-anti-CD8-IgG2asilent), ex vivo 89Zr-labeled ovalbumin-specific CD8+ T cells ([89Zr]Zr-OT-I), and 18F-labeled IL2 ([18F]AlF-RESCA-IL2).

METHODS

B16F10/OVA tumor-bearing C57BL/6 mice (n = 10/group) underwent PET/CT imaging at 72 ([89Zr]Zr-anti-CD8-IgG2asilent), 24 and 48 h ([89Zr]Zr-OT-I), and 10 min ([18F]AlF-RESCA-IL2) pi. Subsequently, biodistribution analysis was performed, followed by flow cytometry to evaluate intratumoral CD8+ T cell numbers. Intratumoral radiolabel distributions were assessed by autoradiography and immunohistochemistry.

RESULTS

All approaches showed uptake in CD8-rich tissues, with preferential spleen targeting. Biodistribution analyses showed tumor uptake exceeded blood level for [89Zr]Zr-anti-CD8-IgG2asilent and [89Zr]Zr-OT-I. Furthermore, their tumor uptake correlated to intratumoral CD8+ T cells presence even though intratumoral distribution patterns differed significantly.

CONCLUSION

[89Zr]Zr-anti-CD8-IgG2asilent and [89Zr]Zr-OT-I PET/CT imaging can evaluate intratumoral CD8+ T cell infiltration. [89Zr]Zr-anti-CD8-IgG2asilent might be suited for TME immunophenotyping, while ex vivo labeling visualizes tumor migration and invasion dynamics of tumor-specific T cells. [18F]AlF-RESCA-IL2 uptake did not correlate to the intratumoral CD8+ T cell presence. Here, we provide new insights to guide the selection of imaging strategies for assessing relevant immunotherapy-specific aspects of the TME and support the correct interpretation of clinical CD8 imaging.

Для цитирования: Sandker Gerwin G W, Raavé René, Antunes Inês F, Boswinkel Milou, Cornelissen Lenneke A M, Franssen Gerben M, Molkenboer-Kuenen Janneke, Wierstra Peter J, Hagemans Iris M, de Vries Erik F J, Bussink Johan, Adema Gosse J, Verdoes Martijn, Aarntzen Erik H J G, Heskamp Sandra. Head-to-head comparison of nuclear imaging approaches to quantify tumor CD8+ T-cell infiltration.. Immunotherapy advances. 2025. DOI: 10.1093/immadv/ltaf027.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.